- IN₹4.82bn
- IN₹1.64bn
- IN₹3.62bn
- 82
- 51
- 21
- 53
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.17 | ||
Price to Tang. Book | 1.17 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.34 | ||
EV to EBITDA | 9.44 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 2.38% | ||
Return on Equity | 10.59% | ||
Operating Margin | 2.88% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 3,207.95 | 2,474.5 | 3,135.11 | 3,415.64 | 3,624.62 | n/a | n/a | 2.72% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +7.36 | +15.73 | +51.74 | +7.92 | +109.78 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.
Directors
- Arun Kothari CHM (64)
- Tarminder Parmar CEO
- Ranadeep Bhattacharya CFO (50)
- Chirag Vora CCO
- P. Jain VPR
- M. Maheshwari VPR
- M. Rathi VPR
- G. Srivastava VPR
- V. Chaudhary GMG
- D. Chitlangia OTH
- D. Ghosh OTH
- Manish Sharma OTH
- Arindam Sarkar DRC
- Prabhawati Kothari NED
- Shirish Belapure NID (66)
- Hemal Kampani NID (57)
- Monjori Mitra NID
- Rajiv Singhi NID (52)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 16th, 1938
- Public Since
- June 14th, 2016
- No. of Shareholders
- 11,266
- No. of Employees
- 1,497
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Bombay Stock Exchange
- Shares in Issue
- 5,707,162

- Address
- 15, Chittaranjan Avenue, 2nd Floor, KOLKATA, 700001
- Web
- https://www.albertdavidindia.com/
- Phone
- +91 3322302330
- Auditors
- L B Jha & Co
Upcoming Events for 524075
Q1 2025 Albert David Ltd Earnings Release
Albert David Ltd Annual Shareholders Meeting
Similar to 524075
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Ambalal Sarabhai Enterprises
Bombay Stock Exchange
FAQ
As of Today at 19:09 UTC, shares in Albert David are trading at IN₹847.50. This share price information is delayed by 15 minutes.
Shares in Albert David last closed at IN₹847.50 and the price had moved by -27.72% over the past 365 days. In terms of relative price strength the Albert David share price has underperformed the S&P BSE 100 Index by -31.91% over the past year.
The overall consensus recommendation for Albert David is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Albert David dividend yield is 1.36% based on the trailing twelve month period.
Last year, Albert David paid a total dividend of IN₹11.50, and it currently has a trailing dividend yield of 1.36%. We do not have any data on when Albert David is to next pay dividends.
We do not have data on when Albert David is to next pay dividends. The historic dividend yield on Albert David shares is currently 1.36%.
To buy shares in Albert David you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹847.50, shares in Albert David had a market capitalisation of IN₹4.82bn.
Here are the trading details for Albert David:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 524075
Based on an overall assessment of its quality, value and momentum Albert David is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Albert David. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -34.51%.
As of the last closing price of IN₹847.50, shares in Albert David were trading -31.01% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Albert David PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹847.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Albert David's management team is headed by:
- Arun Kothari - CHM
- Tarminder Parmar - CEO
- Ranadeep Bhattacharya - CFO
- Chirag Vora - CCO
- P. Jain - VPR
- M. Maheshwari - VPR
- M. Rathi - VPR
- G. Srivastava - VPR
- V. Chaudhary - GMG
- D. Chitlangia - OTH
- D. Ghosh - OTH
- Manish Sharma - OTH
- Arindam Sarkar - DRC
- Prabhawati Kothari - NED
- Shirish Belapure - NID
- Hemal Kampani - NID
- Monjori Mitra - NID
- Rajiv Singhi - NID